The Smart Magazine About Medical Technology Innovations

#29 - In the Cloud

Saving Lives Automatically

/ / /

ZOLL Medical Corporation recently received FDA premarket approval for its Hospital Wearable Defibrillator (HWD). The device offers continuous protection to hospitalized patients at risk for ventricular tachycardia or fibrillation. The company cites evidence that delays in defibrillation increase mortality, as well as complications in those who survive such a crisis.
The HWD represents an additional tool for medical personnel responsible for cardiac disease patients. It facilitates staff operations and affords additional protection to patients, especially those not housed in intensive care units. The device senses dangerous arrhythmias and automatically delivers a corrective shock.
An alert is sent 60 seconds before the shock, giving conscious patients time to delay treatment. The detection algorithm and defibrillation waveform are identical to those in the company’s LifeVest Wearable Defibrillator, designed for out-of-hospital use.

Learn more on external defibrillators on

About the Author

Michael Halpern is a US-born and bred writer with experience in radio. He has lived in southern France for 15 years. Michael is the copy editor of MedicalExpo e-magazine.

Related Posts

Artificial intelligence could revolutionize gene therapy and precision medicine, making...

French echotherapy specialist Theraclion presented its flagship Echopulse device at this year’s...

Another interesting innovation presented at MEDICA was the GastroPanel quick test. This diagnostic...

Style Switcher

Highlight Color:




You can also set your own colors or background from the Admin Panel.